| Issue Date | Title | Author(s) |
| 2021 | DGUV dermatologicist procedere - Update Dermatology Report 2021 | Krohn, S.; Bauer, A.; Drechsel-Schlund, C.; Engel, D.; Fartasch, M.; John, S. M. ; Koellner, A.; Roemer, W.; Wehrmann, W.; Weisshaar, E.; Skudlik, C. |
| 2023 | Implementation and evaluation of an e-learning training concept for the imple- mentation of the German occupational dis- eases legal changes regarding the occupa- tional disease number 5101 | Symanzik, C.; Altenburg, C.; Awe, S.; Palsherm, K.; Marx, M.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. |
| 2022 | Indication and Reimbursement of Costs for Biologics in professional Association Treatment by using the example of Dupilumab: A Basis for Discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. |
| 2020 | Legislative Changes in Occupational Diseases - Effects on Dermatological Practice | Kroh, S.; Drechsel-Schlund, C.; Roemer, W.; Wehrmann, W.; Skudlik, C. |
| 2022 | Novel systemic medications-especially for treatment of atopic dermatitis-within therapies of the employer?s liability insur- ance association-a basis for discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, S.; Skudlik, C. ; John, S. M. |
| 2022 | Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: a basis for discussion | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St; Skudlik, C. ; John, S. M. |
| 2022 | Recommendation: Indication and cost coverage for biologics within therapies of the employer's liability insurance association by the example of Dupilumab: A basis for discussion [Indikation und Kostenübernahme von Biologika im berufsgenossenschaftlichen Heilverfahren am Beispiel von Dupilumab: Eine Diskussionsgrundlage] | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; Brandenburg, St.; Skudlik, C. ; John, S.M. |
| 2022 | Recommendation: long-term therapy of occupational hand eczema with alitretinoin within therapies of the employer's liability insurance association | Symanzik, C.; Altenburg, C.; Awe, S.; Drechsel-Schlund, C.; Nienhaus, A.; John, S. M. |
HOCHSCHULBIBLIOGRAPHIE